Fund Overview of SBI Healthcare Opportunities Fund Direct Plan-growth
-
₹4,026.5 CrAUM
-
₹502.80NAV
-
0.91%Expense Ratio
-
EquityFund Category
Returns of SBI Healthcare Opportunities Fund Direct Plan-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 0.41% | NA | 6.12% |
| 6 Months | 10.68% | NA | 12.92% |
| 1 Year | 4.34% | 4.34% | 6.04% |
| 2 Years | 60.10% | 26.53% | 24.93% |
| 3 Years | 103.56% | 26.73% | 25.71% |
| 5 Years | 149.81% | 20.09% | 19.91% |
| 7 Years | 281.06% | 21.06% | NA |
| 10 Years | 215.84% | 12.19% | 12.78% |
Asset Allocation
equities
96.36%debt instruments
0.08%other assets or cash equivalents
3.56%SBI Healthcare Opportunities Fund Direct Plan-growth is one Equity mutual fund offered by SBI Mutual Fund. the fund aims Long term capital appreciation. Equity investments in stocks of companies in the healthcare sector. It manages assets worth ₹4,026.5 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹436.68 and ₹509.68. The expense ratio stands at 0.91%. Fund Manager Manager Education Fund Manager Manager EducationAbout SBI Healthcare Opportunities Fund Direct Plan-growth
The portfolio allocation consists of 96.36% in equities, 0.08% in debt instruments, 3.56% in other assets or cash equivalents. Managed by Tanmaya Desai, it has delivered a return of 4.34% in the last year, a total return since inception of 17.97%.
Key Metrics of SBI Healthcare Opportunities Fund Direct Plan-growth
-
Standard Deviation13.92%
-
Sharpe Ratio1.37%
-
Alpha4.76%
-
Beta0.84%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 3.56% | -0.93% | 7.79% | 28.31% | 21.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 3.48% | -1.15% | 6.93% | 27.23% | 20.44% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | 2.81% | -1.32% | 1.47% | 22.70% | 17.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | 2.70% | -1.67% | 0.16% | 21.05% | 15.87% |
More funds from SBI Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
SBI Healthcare Opportunities Fund-growth
|
₹4,027 | 1.75% | -0.97% | 3.18% | 7.07% | 25.68% |
|
SBI Healthcare Opportunities Fund-idcw
|
₹4,027 | 1.75% | -0.97% | 3.18% | 7.07% | 25.68% |
|
SBI Healthcare Opportunities Fund Direct Plan-idcw
|
₹4,027 | 1.84% | -0.71% | 3.72% | 8.19% | 27.01% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.61 | 28.31% | 21.50% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.39 | 27.23% | 20.44% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.18 | 21.05% | 15.87% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.36 | 22.70% | 17.55% | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 21.76% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 21.76% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 21.76% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 21.76% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.44% | ₹460.81 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.94% | ₹430.46 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.21% | ₹290.20 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.50% | ₹261.66 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.36% | ₹250.34 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.67% | ₹222.94 Cr |
| Cipla Ltd | Healthcare | 4.63% | ₹186.55 Cr |
| Cipla Ltd | Healthcare | 4.59% | ₹180.40 Cr |
| Lonza Group Ag | Healthcare | 4.09% | ₹164.89 Cr |
| Lupin Ltd | Healthcare | 4.02% | ₹162.04 Cr |
| Lupin Ltd | Healthcare | 4.08% | ₹160.55 Cr |
| Lonza Group Ag | Healthcare | 4.06% | ₹159.76 Cr |
| Repo | Unspecified | 3.85% | ₹151.45 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.70% | ₹145.47 Cr |
| Gland Pharma Ltd | Healthcare | 3.59% | ₹144.54 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.66% | ₹144.13 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.57% | ₹143.76 Cr |
| Gland Pharma Ltd | Healthcare | 3.54% | ₹139.41 Cr |
| Ami Organics Ltd | Healthcare | 3.30% | ₹132.74 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.34% | ₹131.53 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.26% | ₹131.46 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.19% | ₹128.62 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.22% | ₹126.46 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.20% | ₹126.04 Cr |
| Biocon Ltd | Healthcare | 3.11% | ₹125.25 Cr |
| Abbott India Ltd | Healthcare | 3.08% | ₹123.86 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.12% | ₹122.53 Cr |
| Laurus Labs Ltd | Healthcare | 3.04% | ₹122.41 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.00% | ₹120.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.97% | ₹119.74 Cr |
| Concord Biotech Ltd. | Healthcare | 3.02% | ₹118.63 Cr |
| Ami Organics Ltd | Healthcare | 3.02% | ₹118.60 Cr |
| Laurus Labs Ltd | Healthcare | 3.00% | ₹117.85 Cr |
| Abbott India Ltd | Healthcare | 2.98% | ₹117.16 Cr |
| Poly Medicure Ltd | Healthcare | 2.97% | ₹116.89 Cr |
| Concord Biotech Ltd. | Healthcare | 2.85% | ₹114.70 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.84% | ₹114.40 Cr |
| Repo | Unspecified | 2.77% | ₹111.53 Cr |
| Biocon Ltd | Healthcare | 2.77% | ₹109.12 Cr |
| Poly Medicure Ltd | Healthcare | 2.70% | ₹108.52 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.76% | ₹108.50 Cr |
| Aether Industries Ltd | Materials | 2.67% | ₹107.37 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.68% | ₹105.49 Cr |
| Aether Industries Ltd | Materials | 2.68% | ₹105.27 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.50% | ₹100.62 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.32% | ₹91.34 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.26% | ₹91.10 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.12% | ₹85.37 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.98% | ₹79.79 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.93% | ₹75.87 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.86% | ₹74.88 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.60% | ₹64.50 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.53% | ₹60.00 Cr |
| Pfizer Ltd | Healthcare | 1.29% | ₹51.95 Cr |
| Pfizer Ltd | Healthcare | 1.28% | ₹50.36 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹50.02 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.03% | ₹41.54 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.99% | ₹39.71 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.91% | ₹36.81 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.90% | ₹35.45 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.90% | ₹35.40 Cr |
| Medplus Health Services Ltd | Healthcare | 0.87% | ₹34.21 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.08% | ₹2.98 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.07% | ₹2.95 Cr |
| Net Payables | Unspecified | -0.29% | ₹-11.35 Cr |
| Net Payables | Unspecified | -0.44% | ₹-18.70 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.61 | 28.31% | 21.50% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.39 | 27.23% | 20.44% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.36 | 22.70% | 17.55% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.18 | 21.05% | 15.87% | - |
SBI Healthcare Opportunities Fund Direct Plan-growth
What is the current AUM of SBI Healthcare Opportunities Fund Direct Plan-growth?
As of Thu Jul 31, 2025, SBI Healthcare Opportunities Fund Direct Plan-growth manages assets worth ₹4,026.5 crore
How has SBI Healthcare Opportunities Fund Direct Plan-growth performed recently?
- 3 Months: 0.41%
- 6 Months: 10.68%
What is the long-term performance of SBI Healthcare Opportunities Fund Direct Plan-growth?
- 3 Years CAGR: 26.73%
- 5 Years CAGR: 20.09%
- Since Inception: 17.97%
What is the portfolio composition of SBI Healthcare Opportunities Fund Direct Plan-growth?
Equity: 96.36%, Debt: 0.08%, Others: 3.56%.
Who manages SBI Healthcare Opportunities Fund Direct Plan-growth?
SBI Healthcare Opportunities Fund Direct Plan-growth is managed by Tanmaya Desai from SBI Mutual Fund.
What is the market-cap allocation of SBI Healthcare Opportunities Fund Direct Plan-growth?
Large Cap: 44.31%, Mid Cap: 20.20%, Small Cap: 35.49%.
Which are the top companies SBI Healthcare Opportunities Fund Direct Plan-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.44% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.94% of the fund's portfolio
- Divi's Laboratories Ltd – 7.21% of the fund's portfolio
- Max Healthcare Institute Ltd – 6.50% of the fund's portfolio
- Divi's Laboratories Ltd – 6.36% of the fund's portfolio
Which are the major sectors SBI Healthcare Opportunities Fund Direct Plan-growth focuses on?
- Healthcare – 188.61% of the fund's portfolio
- Unspecified – 5.89% of the fund's portfolio
- Materials – 5.35% of the fund's portfolio
- Financial – 0.15% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
